GlassScriptPhysician profile
David Amadu
NPI 1912319989
$1,105.09
in general payments reported to CMS, 2019-2025
8 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2021: $110 · 2022: $97.48 · 2023: $47.75 · 2024: $167 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.20 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $549.11 | 2021-2025 | Smart Port Ct, Alphavac, Soft-Vu |
| Boston Scientific Corporation | $370.67 | 2019-2025 | Opticross 35, Angiojet Ultra 5000a, Varithena Administration Pack |
| Stryker Corporation | $67.46 | 2021-2025 | Flowtriever |
| Argon Medical Devices, INC. | $43.32 | 2024-2025 | Clot Management, Clot Management |
| Biosense Webster, INC. | $29.60 | 2025 | Carto 3 |
| Ethicon US, LLC | $19.62 | 2021 | |
| Chiesi USA, INC. | $14.57 | 2025 | Kengreal |
| Sirtex Medical INC | $10.74 | 2025 | Lava Les (Liquid Embolic System) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Amadu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.